Neonatal necrotizing enterocolitis (NEC) is a serious gastrointestinal disease that primarily affects premature infants, particularly those with low birth weight. It is characterized by inflammation and injury to the intestines, specifically the colon and sometimes the small intestine.
NEC typically occurs within the first few weeks of life, with a peak incidence between the second and fourth weeks. It is more common in preterm infants, especially those born 32 weeks before gestation. Various risk factors contribute to the development of NEC, including prematurity, formula feeding (as opposed to breast milk), intestinal ischemia, bacterial colonization, and a compromised immune system.
The pathophysiology of NEC involves a complex interplay of factors, including intestinal immaturity, compromised blood flow, inflammation, and an abnormal gut microbiome. The initial insult often involves damage to the intestinal lining, followed by bacterial invasion and inflammatory response, which can progress to tissue necrosis and perforation if left untreated.
Treatment typically involves a multidisciplinary approach, including supportive care, such as bowel rest, fluid resuscitation, and nutritional support. In some cases, medical interventions such as antibiotics, antifungal agents, and probiotics may be used.
Epidemiology
Incidence: NEC is primarily seen in neonates, especially premature infants. It is one of the most common gastrointestinal emergencies in the neonatal period.
Gestational Age: Infants who are born 32 weeks before gestation have an increased risk compared to term infants.
Birth Weight: Low birth weight is also associated with an increased risk of NEC. Extremely low birth weight infants have a higher incidence of NEC compared to moderately low birth weight infants.
Age of Onset: NEC typically occurs within the first few weeks of life, with the highest incidence between the second and fourth weeks.
Geographical Variation: The incidence of NEC may vary across different populations and regions. It is more commonly reported in developed countries with advanced neonatal intensive care units (NICUs).
Other Factors: Additional factors that may contribute to the development of NEC include formula feeding (as opposed to exclusive breastfeeding), bacterial colonization, intestinal ischemia, and a compromised immune system.
Anatomy
Pathophysiology
Intestinal Immaturity: The immature intestinal barrier in premature infants is a key factor in the development of NEC. The gastrointestinal tract is not fully developed, making it susceptible to injury and inflammation.
Disrupted Gut Microbiota: Alterations in the gut microbiota, including an overgrowth of harmful bacteria, can contribute to the pathogenesis of NEC. The imbalance in microbial colonization can lead to dysregulation of the immune response and increased susceptibility to inflammation.
Impaired Mucosal Defense: The inadequate production of protective factors, such as mucus and antimicrobial peptides, compromises the mucosal defense mechanisms. This impairs the ability of the intestinal lining to prevent bacterial invasion and inflammatory responses.
Intestinal Ischemia and Hypoxia: NEC is associated with episodes of intestinal ischemia and hypoxia. Reduced blood flow to the intestines can lead to tissue damage, necrosis, and subsequent inflammation.
Inflammatory Response: The initial insult to the intestinal mucosa triggers an inflammatory response, characterized by the release of pro-inflammatory cytokines, chemokines, and immune cell infiltration. Excessive inflammation further damages the intestinal tissue.
Immune Dysfunction: Immune dysregulation, including impaired immune cell function and altered immune responses, plays a role in the pathophysiology of NEC. The immature immune system in premature infants may contribute to an exaggerated inflammatory response.
Etiology
Prematurity: Premature infants, especially those born before 32 weeks of gestation, may have an increased risk of developing NEC. The immaturity of the gastrointestinal tract and other organs increases vulnerability to the disease.
Intestinal Ischemia: Insufficient blood flow to the intestines can lead to ischemia, which is a major contributing factor to NEC. Reduced blood flow can result from factors such as hypoxia, low blood pressure, or blood vessel abnormalities.
Formula Feeding: The use of formula milk as opposed to breast milk has been associated with an increased risk of NEC. Breast milk contains protective factors that help prevent the development of NEC.
Gut Microbiota Imbalance: Alterations in the composition of gut microbiota, such as an overgrowth of harmful bacteria, may contribute to the development of NEC. The disruption of the normal gut microbiota can lead to inflammation and tissue damage.
Immature Immune System: The immune system of premature infants is underdeveloped, making them more susceptible to infections and inflammatory responses. Immune dysfunction can play a role in the pathogenesis of NEC.
Enteral Feeding: The introduction of enteral feeding (feeding through the gastrointestinal tract) is a potential trigger for NEC. The process of feeding can introduce bacteria into the intestines, leading to infection and inflammation.
Genetics
Prognostic Factors
Gestational Age: The gestational age at birth is a significant prognostic factor. Premature infants, particularly those who born before 32 weeks of gestation have an increased risk of complications and poorer outcomes.
Birth Weight: Lower birth weight has been associated with an increased risk of severe NEC and adverse outcomes. Extremely low birth weight infants are at particularly high risk.
Clinical Severity: The severity of NEC at presentation is a prognostic factor. Infants with severe symptoms such as hemodynamic instability, abdominal distention, and systemic manifestations have a poorer prognosis.
Radiographic Findings: Radiographic evidence of advanced disease, including pneumatosis intestinalis (gas within the intestinal wall) and portal venous gas, is associated with a higher risk of complications and worse outcomes.
Surgical Intervention: The need for surgical intervention, such as bowel resection or ostomy, is a significant prognostic factor. Surgery is often required for advanced stages of NEC or in cases of intestinal perforation.
Early Diagnosis and Treatment: Prompt recognition and initiation of appropriate treatment play a crucial role in the prognosis of NEC. Delayed diagnosis and treatment can lead to more severe complications and worse outcomes.
Clinical History
Age Group:
Neonates: NEC primarily affects premature infants, particularly those born before 32 weeks of gestation. However, it can also occur in full-term infants, although less frequently.
Physical Examination
General Appearance:
Assessment of the infant’s overall appearance, including activity level, responsiveness, and signs of distress.
Vital Signs:
Measurement of heart rate, respiratory rate, temperature, and blood pressure to evaluate for signs of systemic illness or instability.
Abdominal Examination:
Inspection: Examination of the abdomen for distention, discoloration, or erythema.
Palpation: Gentle palpation of the abdomen to assess for tenderness, rigidity, or signs of peritonitis.
Auscultation: Listening for bowel sounds, which may be absent or decreased in cases of NEC.
Signs of Sepsis:
Evaluation for signs of systemic infection, such as pallor, cyanosis, mottling of the skin, or petechiae.
Assessment of Hydration Status:
Evaluation of skin turgor, mucous membrane moisture, and capillary refill time to assess hydration status.
Respiratory Examination:
Auscultation of the lungs to evaluate for signs of respiratory distress or infection.
Other Systemic Examination:
Examination of other body systems as appropriate, depending on the infant’s clinical presentation and comorbidities.
Age group
Associated comorbidity
Prematurity: Premature infants with underdeveloped immune systems and immature gastrointestinal tracts are at higher risk for NEC.
Formula Feeding: NEC is more common in infants fed with formula rather than breast milk.
Intestinal Ischemia: Conditions that disrupt blood flow to the intestines, such as hypotension, respiratory distress syndrome, or congenital heart disease, can increase the risk of NEC.
Infection: Neonates with an infection, particularly sepsis, are at an increased risk of developing NEC.
Associated activity
Acuity of presentation
Early Symptoms: NEC often starts with nonspecific signs such as feeding intolerance, abdominal distention, and lethargy.
Progressive Symptoms: As the disease progresses, symptoms may include bilious or bloody vomiting, decreased bowel movements, increased gastric residuals, abdominal tenderness or discoloration, and signs of systemic illness such as temperature instability or apnea.
Severe Symptoms: In severe cases, the infant may develop signs of sepsis, including hypotension, tachycardia, and metabolic acidosis. Bowel perforation or necrosis may lead to peritonitis or pneumatosis intestinalis (gas within the intestinal wall).
Differential Diagnoses
Gastrointestinal Infections:
Sepsis-associated gastrointestinal infections
Viral gastroenteritis
Bacterial enteritis (e.g., Salmonella, Shigella)
Other Bowel Disorders:
Intestinal obstruction (e.g., volvulus, atresia)
Hirschsprung’s disease
Meconium ileus
Intestinal perforation
Metabolic Disorders:
Inborn errors of metabolism (e.g., galactosemia, cystic fibrosis)
Systemic Illnesses:
Sepsis
Pneumonia
Meningitis
Intestinal Ischemia:
Necrotizing enterocolitis (NEC) should be differentiated from other causes of intestinal ischemia, such as midgut volvulus or intestinal atresia.
Supportive care: Supportive care plays a vital role in the treatment of neonatal necrotizing enterocolitis (NEC) and aims to stabilize the infant’s condition, support organ function, and promote healing.
NPO (Nothing Per Oral): Infants with NEC often require temporary cessation of oral feeding to rest the bowel and reduce the risk of complications. They receive nutrition through intravenous fluids or parenteral nutrition to meet their nutritional needs.
Intravenous Fluids: Fluid resuscitation is provided to maintain hydration and electrolyte balance. Intravenous fluids may also contain antibiotics to target any associated infection.
Gastric Decompression: Gastric decompression is achieved through the placement of an orogastric or nasogastric tube to relieve abdominal distention, remove gastric contents, and reduce the risk of bowel perforation.
Vital Sign Monitoring: Frequent monitoring of vital signs i.e., heart rate, blood pressure, oxygen saturation, and temperature, is essential to assess the infant’s stability and detect any signs of deterioration.
Temperature Control: Maintaining a stable body temperature is important to support the infant’s metabolism and prevent hypothermia or hyperthermia, which can worsen the condition.
Respiratory Support: Infants with severe NEC may require respiratory support, such as supplemental oxygen or mechanical ventilation, to ensure adequate oxygenation and ventilation.
Parental Support and Education: Parents of infants with NEC require emotional support and education regarding the condition, its treatment, and potential complications. They should be encouraged to actively participate in their baby’s care and informed about the importance of infection control measures
Choice and duration of antibiotic therapy
The choice of antibiotics should be guided by local susceptibility patterns and the presence of specific pathogens like methicillin-resistant Staphylococcus aureus (MRSA) or ampicillin-resistant enterococci. Acceptable empiric regimens include combinations such as ampicillin plus gentamicin (or amikacin) plus metronidazole or clindamycin, as well as monotherapy with piperacillin-tazobactam or meropenem.
Ampicillin plus gentamicin: This combination provides coverage against Gram-positive organisms (such as Streptococcus and Staphylococcus species) and Gram-negative organisms (such as Escherichia coli and Klebsiella species).
Ampicillin plus cefotaxime: This combination provides broad-spectrum coverage against both Gram-positive and Gram-negative organisms, including some resistant strains.
Ampicillin plus an aminoglycoside (such as amikacin): This combination is often used in cases where there is concern for resistant Gram-negative organisms, such as extended-spectrum beta-lactamase (ESBL)-producing bacteria.
Ampicillin: Ampicillin is effective against Gram-positive bacteria, including Group B Streptococcus and some strains of Escherichia coli. It is often combined with another antibiotic for broader coverage.
Gentamicin: Gentamicin is an aminoglycoside antibiotic that targets Gram-negative bacteria like Escherichia coli and Klebsiella. It is commonly used in combination with ampicillin.
Cefotaxime: Cefotaxime is a third-generation cephalosporin that provides coverage against a wide range of Gram-negative bacteria. It may be used as an alternative to gentamicin.
Metronidazole: Metronidazole is effective against anaerobic bacteria, including Bacteroides fragilis. It is often added to the antibiotic regimen for coverage against anaerobic pathogens.
Vancomycin: This antibiotic is effective against methicillin-resistant Staphylococcus aureus (MRSA) and may be added to the regimen in cases where there is suspicion or confirmation of MRSA infection.
Probiotics: These are live microorganisms that help to restore the balance of gut bacteria. They have shown potential in reducing the incidence and severity of NEC. Commonly used probiotics include strains of Lactobacillus and Bifidobacterium.
Pain Medications: Infants with NEC may experience pain and discomfort. Analgesic medications, such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs), may be used to provide pain relief as deemed appropriate by the healthcare team.
Laparotomy is a surgical procedure commonly used in the treatment of severe cases of Neonatal necrotizing enterocolitis (NEC). It involves making an incision into the abdominal wall to get access to the abdominal cavity and perform necessary interventions. Laparotomy may be indicated in NEC for various reasons, such as:
Bowel exploration: Laparotomy allows surgeons to visually inspect the intestines and assess the extent of necrotic or damaged bowel tissue. It helps identify areas of perforation, strictures, or other complications associated with NEC.
Bowel resection: If a portion of the intestine is severely affected by necrosis or damage, it may need to be surgically removed. Laparotomy provides direct access to perform bowel resection, eliminating the source of infection and preventing further complications.
Peritoneal lavage: In cases of peritonitis or intra-abdominal infection, laparotomy allows for the irrigation and cleansing of the abdominal cavity with sterile fluids to remove infectious material and reduce the risk of complications.
Perforation repair: Laparotomy enables the identification and repair of intestinal perforations, which may be present in severe cases of NEC. The surgeon can close the perforations to restore the integrity of the intestinal wall.
Drainage of abscesses: Laparotomy allows for the drainage of intra-abdominal abscesses that may have developed as a result of NEC. Abscesses are localized collections of pus and infected material, and their drainage helps promote healing and resolution of the infection.
Laparotomy is a major surgical procedure that requires anesthesia and careful post-operative monitoring. The specific details of the laparotomy procedure, including the size and location of incision depend on the individual case and the surgeon’s assessment. Close collaboration between neonatal surgeons, pediatricians, and the multidisciplinary team is essential to ensure optimal management and outcomes for infants with severe NEC requiring laparotomy.
Primary peritoneal drainage can be used in the treatment of Neonatal necrotizing enterocolitis (NEC) in certain cases. It involves the placement of a peritoneal drain to remove fluid and relieve intra-abdominal pressure in infants with severe abdominal distension and suspected or confirmed bowel perforation.
During the procedure, a small incision is made in the abdominal wall, and a drain is inserted into the peritoneal cavity. The drain is connected to a collection system that allows for the continuous or intermittent drainage of fluid. This helps to reduce intra-abdominal pressure and prevent further complications associated with bowel perforation, such as peritonitis or abscess formation.
Primary peritoneal drainage can be a temporary measure to stabilize the infant’s condition and allow for ongoing medical management. It is often performed in cases where the infant is too unstable for immediate surgical intervention or when surgical intervention is not feasible due to various reasons.
management-of-neonatal-necrotizing-enterocolitis
Acute Phase: In the acute phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the primary focus is on prompt diagnosis, bowel rest, and supportive care. This includes withholding oral feedings, initiating intravenous fluids and broad-spectrum antibiotics, and closely monitoring the infant’s clinical condition, laboratory values, and radiographic findings.
Transitional Phase: In the transitional phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the focus shifts towards gradual reintroduction of enteral feedings and monitoring the infant’s response. Close observation for signs of disease recurrence or complications is essential, along with appropriate adjustments in feeding regimen and ongoing antibiotic therapy. Regular clinical evaluations and imaging studies help guide the transition to full enteral feedings and eventual discharge from the hospital.
Convalescent Phase: In the convalescent phase of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the emphasis is on continued monitoring of the infant’s recovery and growth. Close follow-up with healthcare providers, including regular check-ups and developmental assessments, is important to ensure proper healing and to address any long-term consequences of NEC. Nutritional support and appropriate supplementation may be necessary to promote optimal growth and development. Parental education and support play a crucial role in managing the convalescent phase and providing ongoing care for the infant.
Neonatal necrotizing enterocolitis (NEC) is a serious gastrointestinal disease that primarily affects premature infants, particularly those with low birth weight. It is characterized by inflammation and injury to the intestines, specifically the colon and sometimes the small intestine.
NEC typically occurs within the first few weeks of life, with a peak incidence between the second and fourth weeks. It is more common in preterm infants, especially those born 32 weeks before gestation. Various risk factors contribute to the development of NEC, including prematurity, formula feeding (as opposed to breast milk), intestinal ischemia, bacterial colonization, and a compromised immune system.
The pathophysiology of NEC involves a complex interplay of factors, including intestinal immaturity, compromised blood flow, inflammation, and an abnormal gut microbiome. The initial insult often involves damage to the intestinal lining, followed by bacterial invasion and inflammatory response, which can progress to tissue necrosis and perforation if left untreated.
Treatment typically involves a multidisciplinary approach, including supportive care, such as bowel rest, fluid resuscitation, and nutritional support. In some cases, medical interventions such as antibiotics, antifungal agents, and probiotics may be used.
Incidence: NEC is primarily seen in neonates, especially premature infants. It is one of the most common gastrointestinal emergencies in the neonatal period.
Gestational Age: Infants who are born 32 weeks before gestation have an increased risk compared to term infants.
Birth Weight: Low birth weight is also associated with an increased risk of NEC. Extremely low birth weight infants have a higher incidence of NEC compared to moderately low birth weight infants.
Age of Onset: NEC typically occurs within the first few weeks of life, with the highest incidence between the second and fourth weeks.
Geographical Variation: The incidence of NEC may vary across different populations and regions. It is more commonly reported in developed countries with advanced neonatal intensive care units (NICUs).
Other Factors: Additional factors that may contribute to the development of NEC include formula feeding (as opposed to exclusive breastfeeding), bacterial colonization, intestinal ischemia, and a compromised immune system.
Intestinal Immaturity: The immature intestinal barrier in premature infants is a key factor in the development of NEC. The gastrointestinal tract is not fully developed, making it susceptible to injury and inflammation.
Disrupted Gut Microbiota: Alterations in the gut microbiota, including an overgrowth of harmful bacteria, can contribute to the pathogenesis of NEC. The imbalance in microbial colonization can lead to dysregulation of the immune response and increased susceptibility to inflammation.
Impaired Mucosal Defense: The inadequate production of protective factors, such as mucus and antimicrobial peptides, compromises the mucosal defense mechanisms. This impairs the ability of the intestinal lining to prevent bacterial invasion and inflammatory responses.
Intestinal Ischemia and Hypoxia: NEC is associated with episodes of intestinal ischemia and hypoxia. Reduced blood flow to the intestines can lead to tissue damage, necrosis, and subsequent inflammation.
Inflammatory Response: The initial insult to the intestinal mucosa triggers an inflammatory response, characterized by the release of pro-inflammatory cytokines, chemokines, and immune cell infiltration. Excessive inflammation further damages the intestinal tissue.
Immune Dysfunction: Immune dysregulation, including impaired immune cell function and altered immune responses, plays a role in the pathophysiology of NEC. The immature immune system in premature infants may contribute to an exaggerated inflammatory response.
Prematurity: Premature infants, especially those born before 32 weeks of gestation, may have an increased risk of developing NEC. The immaturity of the gastrointestinal tract and other organs increases vulnerability to the disease.
Intestinal Ischemia: Insufficient blood flow to the intestines can lead to ischemia, which is a major contributing factor to NEC. Reduced blood flow can result from factors such as hypoxia, low blood pressure, or blood vessel abnormalities.
Formula Feeding: The use of formula milk as opposed to breast milk has been associated with an increased risk of NEC. Breast milk contains protective factors that help prevent the development of NEC.
Gut Microbiota Imbalance: Alterations in the composition of gut microbiota, such as an overgrowth of harmful bacteria, may contribute to the development of NEC. The disruption of the normal gut microbiota can lead to inflammation and tissue damage.
Immature Immune System: The immune system of premature infants is underdeveloped, making them more susceptible to infections and inflammatory responses. Immune dysfunction can play a role in the pathogenesis of NEC.
Enteral Feeding: The introduction of enteral feeding (feeding through the gastrointestinal tract) is a potential trigger for NEC. The process of feeding can introduce bacteria into the intestines, leading to infection and inflammation.
Gestational Age: The gestational age at birth is a significant prognostic factor. Premature infants, particularly those who born before 32 weeks of gestation have an increased risk of complications and poorer outcomes.
Birth Weight: Lower birth weight has been associated with an increased risk of severe NEC and adverse outcomes. Extremely low birth weight infants are at particularly high risk.
Clinical Severity: The severity of NEC at presentation is a prognostic factor. Infants with severe symptoms such as hemodynamic instability, abdominal distention, and systemic manifestations have a poorer prognosis.
Radiographic Findings: Radiographic evidence of advanced disease, including pneumatosis intestinalis (gas within the intestinal wall) and portal venous gas, is associated with a higher risk of complications and worse outcomes.
Surgical Intervention: The need for surgical intervention, such as bowel resection or ostomy, is a significant prognostic factor. Surgery is often required for advanced stages of NEC or in cases of intestinal perforation.
Early Diagnosis and Treatment: Prompt recognition and initiation of appropriate treatment play a crucial role in the prognosis of NEC. Delayed diagnosis and treatment can lead to more severe complications and worse outcomes.
Age Group:
Neonates: NEC primarily affects premature infants, particularly those born before 32 weeks of gestation. However, it can also occur in full-term infants, although less frequently.
General Appearance:
Assessment of the infant’s overall appearance, including activity level, responsiveness, and signs of distress.
Vital Signs:
Measurement of heart rate, respiratory rate, temperature, and blood pressure to evaluate for signs of systemic illness or instability.
Abdominal Examination:
Inspection: Examination of the abdomen for distention, discoloration, or erythema.
Palpation: Gentle palpation of the abdomen to assess for tenderness, rigidity, or signs of peritonitis.
Auscultation: Listening for bowel sounds, which may be absent or decreased in cases of NEC.
Signs of Sepsis:
Evaluation for signs of systemic infection, such as pallor, cyanosis, mottling of the skin, or petechiae.
Assessment of Hydration Status:
Evaluation of skin turgor, mucous membrane moisture, and capillary refill time to assess hydration status.
Respiratory Examination:
Auscultation of the lungs to evaluate for signs of respiratory distress or infection.
Other Systemic Examination:
Examination of other body systems as appropriate, depending on the infant’s clinical presentation and comorbidities.
Prematurity: Premature infants with underdeveloped immune systems and immature gastrointestinal tracts are at higher risk for NEC.
Formula Feeding: NEC is more common in infants fed with formula rather than breast milk.
Intestinal Ischemia: Conditions that disrupt blood flow to the intestines, such as hypotension, respiratory distress syndrome, or congenital heart disease, can increase the risk of NEC.
Infection: Neonates with an infection, particularly sepsis, are at an increased risk of developing NEC.
Early Symptoms: NEC often starts with nonspecific signs such as feeding intolerance, abdominal distention, and lethargy.
Progressive Symptoms: As the disease progresses, symptoms may include bilious or bloody vomiting, decreased bowel movements, increased gastric residuals, abdominal tenderness or discoloration, and signs of systemic illness such as temperature instability or apnea.
Severe Symptoms: In severe cases, the infant may develop signs of sepsis, including hypotension, tachycardia, and metabolic acidosis. Bowel perforation or necrosis may lead to peritonitis or pneumatosis intestinalis (gas within the intestinal wall).
Gastrointestinal Infections:
Sepsis-associated gastrointestinal infections
Viral gastroenteritis
Bacterial enteritis (e.g., Salmonella, Shigella)
Other Bowel Disorders:
Intestinal obstruction (e.g., volvulus, atresia)
Hirschsprung’s disease
Meconium ileus
Intestinal perforation
Metabolic Disorders:
Inborn errors of metabolism (e.g., galactosemia, cystic fibrosis)
Systemic Illnesses:
Sepsis
Pneumonia
Meningitis
Intestinal Ischemia:
Necrotizing enterocolitis (NEC) should be differentiated from other causes of intestinal ischemia, such as midgut volvulus or intestinal atresia.
Stabilization: Initial management involves supportive care, including respiratory support, fluid resuscitation, and electrolyte balance.
Bowel Rest: Infants with suspected or confirmed NEC are usually kept nil per os (NPO) to rest the bowel and prevent further injury.
Antibiotic Therapy:
Empiric Antibiotics: Broad-spectrum antibiotics are initiated to cover common pathogens, and the choice is guided by local susceptibility patterns.
Adjustments: Antibiotics may be modified based on culture results and clinical response.
Nutritional Support:
Parenteral Nutrition: In the acute phase, infants are often provided with total parenteral nutrition (TPN) to meet their nutritional needs.
Enteral Feeding: Once the infant’s condition stabilizes, enteral feeding is gradually reintroduced to support gut adaptation and function.
Surgical Intervention:
Indications: Surgery is considered in severe cases of NEC with evidence of bowel perforation, necrosis, or peritonitis.
Procedures: Surgical options include laparotomy, bowel resection, primary peritoneal drainage, or ostomy creation.
Monitoring and Observation:
Radiological Imaging: Regular abdominal X-rays or ultrasounds are performed to monitor the progress and detect complications.
Laboratory Tests: Serial blood tests, including complete blood count, electrolytes, and inflammatory markers, help assess the response to treatment.
Long-Term Management:
Nutritional Optimization: Gradual transition from parenteral to enteral feeding, aiming for full enteral nutrition.
Follow-up Care: Regular monitoring of growth, development, and potential long-term complications associated with NEC.
Supportive care: Supportive care plays a vital role in the treatment of neonatal necrotizing enterocolitis (NEC) and aims to stabilize the infant’s condition, support organ function, and promote healing.
NPO (Nothing Per Oral): Infants with NEC often require temporary cessation of oral feeding to rest the bowel and reduce the risk of complications. They receive nutrition through intravenous fluids or parenteral nutrition to meet their nutritional needs.
Intravenous Fluids: Fluid resuscitation is provided to maintain hydration and electrolyte balance. Intravenous fluids may also contain antibiotics to target any associated infection.
Gastric Decompression: Gastric decompression is achieved through the placement of an orogastric or nasogastric tube to relieve abdominal distention, remove gastric contents, and reduce the risk of bowel perforation.
Vital Sign Monitoring: Frequent monitoring of vital signs i.e., heart rate, blood pressure, oxygen saturation, and temperature, is essential to assess the infant’s stability and detect any signs of deterioration.
Temperature Control: Maintaining a stable body temperature is important to support the infant’s metabolism and prevent hypothermia or hyperthermia, which can worsen the condition.
Respiratory Support: Infants with severe NEC may require respiratory support, such as supplemental oxygen or mechanical ventilation, to ensure adequate oxygenation and ventilation.
Parental Support and Education: Parents of infants with NEC require emotional support and education regarding the condition, its treatment, and potential complications. They should be encouraged to actively participate in their baby’s care and informed about the importance of infection control measures
The choice of antibiotics should be guided by local susceptibility patterns and the presence of specific pathogens like methicillin-resistant Staphylococcus aureus (MRSA) or ampicillin-resistant enterococci. Acceptable empiric regimens include combinations such as ampicillin plus gentamicin (or amikacin) plus metronidazole or clindamycin, as well as monotherapy with piperacillin-tazobactam or meropenem.
Ampicillin plus gentamicin: This combination provides coverage against Gram-positive organisms (such as Streptococcus and Staphylococcus species) and Gram-negative organisms (such as Escherichia coli and Klebsiella species).
Ampicillin plus cefotaxime: This combination provides broad-spectrum coverage against both Gram-positive and Gram-negative organisms, including some resistant strains.
Ampicillin plus an aminoglycoside (such as amikacin): This combination is often used in cases where there is concern for resistant Gram-negative organisms, such as extended-spectrum beta-lactamase (ESBL)-producing bacteria.
Ampicillin: Ampicillin is effective against Gram-positive bacteria, including Group B Streptococcus and some strains of Escherichia coli. It is often combined with another antibiotic for broader coverage.
Gentamicin: Gentamicin is an aminoglycoside antibiotic that targets Gram-negative bacteria like Escherichia coli and Klebsiella. It is commonly used in combination with ampicillin.
Cefotaxime: Cefotaxime is a third-generation cephalosporin that provides coverage against a wide range of Gram-negative bacteria. It may be used as an alternative to gentamicin.
Metronidazole: Metronidazole is effective against anaerobic bacteria, including Bacteroides fragilis. It is often added to the antibiotic regimen for coverage against anaerobic pathogens.
Vancomycin: This antibiotic is effective against methicillin-resistant Staphylococcus aureus (MRSA) and may be added to the regimen in cases where there is suspicion or confirmation of MRSA infection.
Probiotics: These are live microorganisms that help to restore the balance of gut bacteria. They have shown potential in reducing the incidence and severity of NEC. Commonly used probiotics include strains of Lactobacillus and Bifidobacterium.
Pain Medications: Infants with NEC may experience pain and discomfort. Analgesic medications, such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs), may be used to provide pain relief as deemed appropriate by the healthcare team.
Laparotomy is a surgical procedure commonly used in the treatment of severe cases of Neonatal necrotizing enterocolitis (NEC). It involves making an incision into the abdominal wall to get access to the abdominal cavity and perform necessary interventions. Laparotomy may be indicated in NEC for various reasons, such as:
Bowel exploration: Laparotomy allows surgeons to visually inspect the intestines and assess the extent of necrotic or damaged bowel tissue. It helps identify areas of perforation, strictures, or other complications associated with NEC.
Bowel resection: If a portion of the intestine is severely affected by necrosis or damage, it may need to be surgically removed. Laparotomy provides direct access to perform bowel resection, eliminating the source of infection and preventing further complications.
Peritoneal lavage: In cases of peritonitis or intra-abdominal infection, laparotomy allows for the irrigation and cleansing of the abdominal cavity with sterile fluids to remove infectious material and reduce the risk of complications.
Perforation repair: Laparotomy enables the identification and repair of intestinal perforations, which may be present in severe cases of NEC. The surgeon can close the perforations to restore the integrity of the intestinal wall.
Drainage of abscesses: Laparotomy allows for the drainage of intra-abdominal abscesses that may have developed as a result of NEC. Abscesses are localized collections of pus and infected material, and their drainage helps promote healing and resolution of the infection.
Laparotomy is a major surgical procedure that requires anesthesia and careful post-operative monitoring. The specific details of the laparotomy procedure, including the size and location of incision depend on the individual case and the surgeon’s assessment. Close collaboration between neonatal surgeons, pediatricians, and the multidisciplinary team is essential to ensure optimal management and outcomes for infants with severe NEC requiring laparotomy.
Primary peritoneal drainage can be used in the treatment of Neonatal necrotizing enterocolitis (NEC) in certain cases. It involves the placement of a peritoneal drain to remove fluid and relieve intra-abdominal pressure in infants with severe abdominal distension and suspected or confirmed bowel perforation.
During the procedure, a small incision is made in the abdominal wall, and a drain is inserted into the peritoneal cavity. The drain is connected to a collection system that allows for the continuous or intermittent drainage of fluid. This helps to reduce intra-abdominal pressure and prevent further complications associated with bowel perforation, such as peritonitis or abscess formation.
Primary peritoneal drainage can be a temporary measure to stabilize the infant’s condition and allow for ongoing medical management. It is often performed in cases where the infant is too unstable for immediate surgical intervention or when surgical intervention is not feasible due to various reasons.
Acute Phase: In the acute phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the primary focus is on prompt diagnosis, bowel rest, and supportive care. This includes withholding oral feedings, initiating intravenous fluids and broad-spectrum antibiotics, and closely monitoring the infant’s clinical condition, laboratory values, and radiographic findings.
Transitional Phase: In the transitional phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the focus shifts towards gradual reintroduction of enteral feedings and monitoring the infant’s response. Close observation for signs of disease recurrence or complications is essential, along with appropriate adjustments in feeding regimen and ongoing antibiotic therapy. Regular clinical evaluations and imaging studies help guide the transition to full enteral feedings and eventual discharge from the hospital.
Convalescent Phase: In the convalescent phase of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the emphasis is on continued monitoring of the infant’s recovery and growth. Close follow-up with healthcare providers, including regular check-ups and developmental assessments, is important to ensure proper healing and to address any long-term consequences of NEC. Nutritional support and appropriate supplementation may be necessary to promote optimal growth and development. Parental education and support play a crucial role in managing the convalescent phase and providing ongoing care for the infant.
Neonatal necrotizing enterocolitis (NEC) is a serious gastrointestinal disease that primarily affects premature infants, particularly those with low birth weight. It is characterized by inflammation and injury to the intestines, specifically the colon and sometimes the small intestine.
NEC typically occurs within the first few weeks of life, with a peak incidence between the second and fourth weeks. It is more common in preterm infants, especially those born 32 weeks before gestation. Various risk factors contribute to the development of NEC, including prematurity, formula feeding (as opposed to breast milk), intestinal ischemia, bacterial colonization, and a compromised immune system.
The pathophysiology of NEC involves a complex interplay of factors, including intestinal immaturity, compromised blood flow, inflammation, and an abnormal gut microbiome. The initial insult often involves damage to the intestinal lining, followed by bacterial invasion and inflammatory response, which can progress to tissue necrosis and perforation if left untreated.
Treatment typically involves a multidisciplinary approach, including supportive care, such as bowel rest, fluid resuscitation, and nutritional support. In some cases, medical interventions such as antibiotics, antifungal agents, and probiotics may be used.
Incidence: NEC is primarily seen in neonates, especially premature infants. It is one of the most common gastrointestinal emergencies in the neonatal period.
Gestational Age: Infants who are born 32 weeks before gestation have an increased risk compared to term infants.
Birth Weight: Low birth weight is also associated with an increased risk of NEC. Extremely low birth weight infants have a higher incidence of NEC compared to moderately low birth weight infants.
Age of Onset: NEC typically occurs within the first few weeks of life, with the highest incidence between the second and fourth weeks.
Geographical Variation: The incidence of NEC may vary across different populations and regions. It is more commonly reported in developed countries with advanced neonatal intensive care units (NICUs).
Other Factors: Additional factors that may contribute to the development of NEC include formula feeding (as opposed to exclusive breastfeeding), bacterial colonization, intestinal ischemia, and a compromised immune system.
Intestinal Immaturity: The immature intestinal barrier in premature infants is a key factor in the development of NEC. The gastrointestinal tract is not fully developed, making it susceptible to injury and inflammation.
Disrupted Gut Microbiota: Alterations in the gut microbiota, including an overgrowth of harmful bacteria, can contribute to the pathogenesis of NEC. The imbalance in microbial colonization can lead to dysregulation of the immune response and increased susceptibility to inflammation.
Impaired Mucosal Defense: The inadequate production of protective factors, such as mucus and antimicrobial peptides, compromises the mucosal defense mechanisms. This impairs the ability of the intestinal lining to prevent bacterial invasion and inflammatory responses.
Intestinal Ischemia and Hypoxia: NEC is associated with episodes of intestinal ischemia and hypoxia. Reduced blood flow to the intestines can lead to tissue damage, necrosis, and subsequent inflammation.
Inflammatory Response: The initial insult to the intestinal mucosa triggers an inflammatory response, characterized by the release of pro-inflammatory cytokines, chemokines, and immune cell infiltration. Excessive inflammation further damages the intestinal tissue.
Immune Dysfunction: Immune dysregulation, including impaired immune cell function and altered immune responses, plays a role in the pathophysiology of NEC. The immature immune system in premature infants may contribute to an exaggerated inflammatory response.
Prematurity: Premature infants, especially those born before 32 weeks of gestation, may have an increased risk of developing NEC. The immaturity of the gastrointestinal tract and other organs increases vulnerability to the disease.
Intestinal Ischemia: Insufficient blood flow to the intestines can lead to ischemia, which is a major contributing factor to NEC. Reduced blood flow can result from factors such as hypoxia, low blood pressure, or blood vessel abnormalities.
Formula Feeding: The use of formula milk as opposed to breast milk has been associated with an increased risk of NEC. Breast milk contains protective factors that help prevent the development of NEC.
Gut Microbiota Imbalance: Alterations in the composition of gut microbiota, such as an overgrowth of harmful bacteria, may contribute to the development of NEC. The disruption of the normal gut microbiota can lead to inflammation and tissue damage.
Immature Immune System: The immune system of premature infants is underdeveloped, making them more susceptible to infections and inflammatory responses. Immune dysfunction can play a role in the pathogenesis of NEC.
Enteral Feeding: The introduction of enteral feeding (feeding through the gastrointestinal tract) is a potential trigger for NEC. The process of feeding can introduce bacteria into the intestines, leading to infection and inflammation.
Gestational Age: The gestational age at birth is a significant prognostic factor. Premature infants, particularly those who born before 32 weeks of gestation have an increased risk of complications and poorer outcomes.
Birth Weight: Lower birth weight has been associated with an increased risk of severe NEC and adverse outcomes. Extremely low birth weight infants are at particularly high risk.
Clinical Severity: The severity of NEC at presentation is a prognostic factor. Infants with severe symptoms such as hemodynamic instability, abdominal distention, and systemic manifestations have a poorer prognosis.
Radiographic Findings: Radiographic evidence of advanced disease, including pneumatosis intestinalis (gas within the intestinal wall) and portal venous gas, is associated with a higher risk of complications and worse outcomes.
Surgical Intervention: The need for surgical intervention, such as bowel resection or ostomy, is a significant prognostic factor. Surgery is often required for advanced stages of NEC or in cases of intestinal perforation.
Early Diagnosis and Treatment: Prompt recognition and initiation of appropriate treatment play a crucial role in the prognosis of NEC. Delayed diagnosis and treatment can lead to more severe complications and worse outcomes.
Age Group:
Neonates: NEC primarily affects premature infants, particularly those born before 32 weeks of gestation. However, it can also occur in full-term infants, although less frequently.
General Appearance:
Assessment of the infant’s overall appearance, including activity level, responsiveness, and signs of distress.
Vital Signs:
Measurement of heart rate, respiratory rate, temperature, and blood pressure to evaluate for signs of systemic illness or instability.
Abdominal Examination:
Inspection: Examination of the abdomen for distention, discoloration, or erythema.
Palpation: Gentle palpation of the abdomen to assess for tenderness, rigidity, or signs of peritonitis.
Auscultation: Listening for bowel sounds, which may be absent or decreased in cases of NEC.
Signs of Sepsis:
Evaluation for signs of systemic infection, such as pallor, cyanosis, mottling of the skin, or petechiae.
Assessment of Hydration Status:
Evaluation of skin turgor, mucous membrane moisture, and capillary refill time to assess hydration status.
Respiratory Examination:
Auscultation of the lungs to evaluate for signs of respiratory distress or infection.
Other Systemic Examination:
Examination of other body systems as appropriate, depending on the infant’s clinical presentation and comorbidities.
Prematurity: Premature infants with underdeveloped immune systems and immature gastrointestinal tracts are at higher risk for NEC.
Formula Feeding: NEC is more common in infants fed with formula rather than breast milk.
Intestinal Ischemia: Conditions that disrupt blood flow to the intestines, such as hypotension, respiratory distress syndrome, or congenital heart disease, can increase the risk of NEC.
Infection: Neonates with an infection, particularly sepsis, are at an increased risk of developing NEC.
Early Symptoms: NEC often starts with nonspecific signs such as feeding intolerance, abdominal distention, and lethargy.
Progressive Symptoms: As the disease progresses, symptoms may include bilious or bloody vomiting, decreased bowel movements, increased gastric residuals, abdominal tenderness or discoloration, and signs of systemic illness such as temperature instability or apnea.
Severe Symptoms: In severe cases, the infant may develop signs of sepsis, including hypotension, tachycardia, and metabolic acidosis. Bowel perforation or necrosis may lead to peritonitis or pneumatosis intestinalis (gas within the intestinal wall).
Gastrointestinal Infections:
Sepsis-associated gastrointestinal infections
Viral gastroenteritis
Bacterial enteritis (e.g., Salmonella, Shigella)
Other Bowel Disorders:
Intestinal obstruction (e.g., volvulus, atresia)
Hirschsprung’s disease
Meconium ileus
Intestinal perforation
Metabolic Disorders:
Inborn errors of metabolism (e.g., galactosemia, cystic fibrosis)
Systemic Illnesses:
Sepsis
Pneumonia
Meningitis
Intestinal Ischemia:
Necrotizing enterocolitis (NEC) should be differentiated from other causes of intestinal ischemia, such as midgut volvulus or intestinal atresia.
Stabilization: Initial management involves supportive care, including respiratory support, fluid resuscitation, and electrolyte balance.
Bowel Rest: Infants with suspected or confirmed NEC are usually kept nil per os (NPO) to rest the bowel and prevent further injury.
Antibiotic Therapy:
Empiric Antibiotics: Broad-spectrum antibiotics are initiated to cover common pathogens, and the choice is guided by local susceptibility patterns.
Adjustments: Antibiotics may be modified based on culture results and clinical response.
Nutritional Support:
Parenteral Nutrition: In the acute phase, infants are often provided with total parenteral nutrition (TPN) to meet their nutritional needs.
Enteral Feeding: Once the infant’s condition stabilizes, enteral feeding is gradually reintroduced to support gut adaptation and function.
Surgical Intervention:
Indications: Surgery is considered in severe cases of NEC with evidence of bowel perforation, necrosis, or peritonitis.
Procedures: Surgical options include laparotomy, bowel resection, primary peritoneal drainage, or ostomy creation.
Monitoring and Observation:
Radiological Imaging: Regular abdominal X-rays or ultrasounds are performed to monitor the progress and detect complications.
Laboratory Tests: Serial blood tests, including complete blood count, electrolytes, and inflammatory markers, help assess the response to treatment.
Long-Term Management:
Nutritional Optimization: Gradual transition from parenteral to enteral feeding, aiming for full enteral nutrition.
Follow-up Care: Regular monitoring of growth, development, and potential long-term complications associated with NEC.
Supportive care: Supportive care plays a vital role in the treatment of neonatal necrotizing enterocolitis (NEC) and aims to stabilize the infant’s condition, support organ function, and promote healing.
NPO (Nothing Per Oral): Infants with NEC often require temporary cessation of oral feeding to rest the bowel and reduce the risk of complications. They receive nutrition through intravenous fluids or parenteral nutrition to meet their nutritional needs.
Intravenous Fluids: Fluid resuscitation is provided to maintain hydration and electrolyte balance. Intravenous fluids may also contain antibiotics to target any associated infection.
Gastric Decompression: Gastric decompression is achieved through the placement of an orogastric or nasogastric tube to relieve abdominal distention, remove gastric contents, and reduce the risk of bowel perforation.
Vital Sign Monitoring: Frequent monitoring of vital signs i.e., heart rate, blood pressure, oxygen saturation, and temperature, is essential to assess the infant’s stability and detect any signs of deterioration.
Temperature Control: Maintaining a stable body temperature is important to support the infant’s metabolism and prevent hypothermia or hyperthermia, which can worsen the condition.
Respiratory Support: Infants with severe NEC may require respiratory support, such as supplemental oxygen or mechanical ventilation, to ensure adequate oxygenation and ventilation.
Parental Support and Education: Parents of infants with NEC require emotional support and education regarding the condition, its treatment, and potential complications. They should be encouraged to actively participate in their baby’s care and informed about the importance of infection control measures
The choice of antibiotics should be guided by local susceptibility patterns and the presence of specific pathogens like methicillin-resistant Staphylococcus aureus (MRSA) or ampicillin-resistant enterococci. Acceptable empiric regimens include combinations such as ampicillin plus gentamicin (or amikacin) plus metronidazole or clindamycin, as well as monotherapy with piperacillin-tazobactam or meropenem.
Ampicillin plus gentamicin: This combination provides coverage against Gram-positive organisms (such as Streptococcus and Staphylococcus species) and Gram-negative organisms (such as Escherichia coli and Klebsiella species).
Ampicillin plus cefotaxime: This combination provides broad-spectrum coverage against both Gram-positive and Gram-negative organisms, including some resistant strains.
Ampicillin plus an aminoglycoside (such as amikacin): This combination is often used in cases where there is concern for resistant Gram-negative organisms, such as extended-spectrum beta-lactamase (ESBL)-producing bacteria.
Ampicillin: Ampicillin is effective against Gram-positive bacteria, including Group B Streptococcus and some strains of Escherichia coli. It is often combined with another antibiotic for broader coverage.
Gentamicin: Gentamicin is an aminoglycoside antibiotic that targets Gram-negative bacteria like Escherichia coli and Klebsiella. It is commonly used in combination with ampicillin.
Cefotaxime: Cefotaxime is a third-generation cephalosporin that provides coverage against a wide range of Gram-negative bacteria. It may be used as an alternative to gentamicin.
Metronidazole: Metronidazole is effective against anaerobic bacteria, including Bacteroides fragilis. It is often added to the antibiotic regimen for coverage against anaerobic pathogens.
Vancomycin: This antibiotic is effective against methicillin-resistant Staphylococcus aureus (MRSA) and may be added to the regimen in cases where there is suspicion or confirmation of MRSA infection.
Probiotics: These are live microorganisms that help to restore the balance of gut bacteria. They have shown potential in reducing the incidence and severity of NEC. Commonly used probiotics include strains of Lactobacillus and Bifidobacterium.
Pain Medications: Infants with NEC may experience pain and discomfort. Analgesic medications, such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs), may be used to provide pain relief as deemed appropriate by the healthcare team.
Laparotomy is a surgical procedure commonly used in the treatment of severe cases of Neonatal necrotizing enterocolitis (NEC). It involves making an incision into the abdominal wall to get access to the abdominal cavity and perform necessary interventions. Laparotomy may be indicated in NEC for various reasons, such as:
Bowel exploration: Laparotomy allows surgeons to visually inspect the intestines and assess the extent of necrotic or damaged bowel tissue. It helps identify areas of perforation, strictures, or other complications associated with NEC.
Bowel resection: If a portion of the intestine is severely affected by necrosis or damage, it may need to be surgically removed. Laparotomy provides direct access to perform bowel resection, eliminating the source of infection and preventing further complications.
Peritoneal lavage: In cases of peritonitis or intra-abdominal infection, laparotomy allows for the irrigation and cleansing of the abdominal cavity with sterile fluids to remove infectious material and reduce the risk of complications.
Perforation repair: Laparotomy enables the identification and repair of intestinal perforations, which may be present in severe cases of NEC. The surgeon can close the perforations to restore the integrity of the intestinal wall.
Drainage of abscesses: Laparotomy allows for the drainage of intra-abdominal abscesses that may have developed as a result of NEC. Abscesses are localized collections of pus and infected material, and their drainage helps promote healing and resolution of the infection.
Laparotomy is a major surgical procedure that requires anesthesia and careful post-operative monitoring. The specific details of the laparotomy procedure, including the size and location of incision depend on the individual case and the surgeon’s assessment. Close collaboration between neonatal surgeons, pediatricians, and the multidisciplinary team is essential to ensure optimal management and outcomes for infants with severe NEC requiring laparotomy.
Primary peritoneal drainage can be used in the treatment of Neonatal necrotizing enterocolitis (NEC) in certain cases. It involves the placement of a peritoneal drain to remove fluid and relieve intra-abdominal pressure in infants with severe abdominal distension and suspected or confirmed bowel perforation.
During the procedure, a small incision is made in the abdominal wall, and a drain is inserted into the peritoneal cavity. The drain is connected to a collection system that allows for the continuous or intermittent drainage of fluid. This helps to reduce intra-abdominal pressure and prevent further complications associated with bowel perforation, such as peritonitis or abscess formation.
Primary peritoneal drainage can be a temporary measure to stabilize the infant’s condition and allow for ongoing medical management. It is often performed in cases where the infant is too unstable for immediate surgical intervention or when surgical intervention is not feasible due to various reasons.
Acute Phase: In the acute phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the primary focus is on prompt diagnosis, bowel rest, and supportive care. This includes withholding oral feedings, initiating intravenous fluids and broad-spectrum antibiotics, and closely monitoring the infant’s clinical condition, laboratory values, and radiographic findings.
Transitional Phase: In the transitional phases of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the focus shifts towards gradual reintroduction of enteral feedings and monitoring the infant’s response. Close observation for signs of disease recurrence or complications is essential, along with appropriate adjustments in feeding regimen and ongoing antibiotic therapy. Regular clinical evaluations and imaging studies help guide the transition to full enteral feedings and eventual discharge from the hospital.
Convalescent Phase: In the convalescent phase of management in the treatment of Neonatal necrotizing enterocolitis (NEC), the emphasis is on continued monitoring of the infant’s recovery and growth. Close follow-up with healthcare providers, including regular check-ups and developmental assessments, is important to ensure proper healing and to address any long-term consequences of NEC. Nutritional support and appropriate supplementation may be necessary to promote optimal growth and development. Parental education and support play a crucial role in managing the convalescent phase and providing ongoing care for the infant.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
